Keterangan
Product Properties
|
Alternative Names |
FSH alpha & FSH beta,FSH alphaβFSH alpha,beta |
|
Species |
Human |
|
Expression Sequence |
Ala25-Ser116 (FSH alpha) & Asn19-Glu129 (FSH beta) |
|
Accession |
P01215(FSH alpha)&P01225 (FSH beta) |
|
Tag |
C-hFc |
|
Expression System |
HEK293 |
|
Molecular Weight |
The protein has a predicted MW of 10.20 kDa (FSH alpha) and 39.2 kDa (FSH beta). Due to glycosylation, the protein migrates to 25-30 kDa (FSH alpha) and 50-60 kDa (FSH beta) based on SDS-PAGE result. |
|
Purity |
> 95% as determined by SDS-PAGE and HPLC. |
|
Endotoxin |
< 1.0 EU per μg by the LAL method. |
|
Formulation |
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
|
Appearance |
Lyophilized Powder |
|
Reconstitution Method |
1. Centrifuge before opening2. Reconstitute with distilled water (>100 μg/mL)3. Aliquot to avoid freeze-thaw cycles |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Lyophilized powder: Store at -25 to -15°C; stable for 1 year upon receipt.
Pembayaran & Keamanan
Informasi pembayaran Anda diproses dengan aman. Kami tidak menyimpan detail kartu kredit atau memiliki akses ke informasi kartu kredit Anda.
Pertanyaan
Anda mungkin juga menyukai
FAQ
Produk ini hanya untuk keperluan penelitian dan tidak ditujukan untuk penggunaan terapeutik atau diagnostik pada manusia atau hewan. Produk dan konten dilindungi oleh paten, merek dagang, dan hak cipta milik
Aplikasi tertentu mungkin memerlukan hak kekayaan intelektual pihak ketiga tambahan.